Company intelligence
Global Health Innovative Technology (GHIT) Fund
About Global Health Innovative Technology (GHIT) Fund
The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, and international philanthropic foundations.
Verified activity
Signals from Global Health Innovative Technology (GHIT) Fund
4 published signals
Research & Knowledge
Global Health Innovative Technology (GHIT) Fund announced a new pediatric formulation for preschoolers under the Schistosomiasis R&D Project led by Dr. Hiroyuki Kojima.
Reported by Global Health Innovative Technology (GHIT) Fund
Partnerships
Global Health Innovative Technology (GHIT) Fund provided two rounds of funding to support the preclinical development of AID351 through the collaboration between Chugai Pharmaceutical Co., Ltd. and A*STAR Singapore Immunology Network (A*STAR SIgN). Under the new agreement, GSK will lead the clinical development, including Phase I trials, and manufacturing of AID351.
Reported by Global Health Innovative Technology (GHIT) Fund
Presence & Recognition
Global Health Innovative Technology (GHIT) Fund announced that the 13th NIKKEI Communicable Diseases Conference will be held on October 27–28, 2026, with the 13th NIKKEI Communicable Diseases Conference theme of What Is Expected of Japan in an Increasingly Unstable World.
Reported by Global Health Innovative Technology (GHIT) Fund
Presence & Recognition
Global Health Innovative Technology (GHIT) Fund hosted a highlight video from a recent malaria event co-hosted by Medicines for Malaria Venture and GHIT Fund.
Reported by Global Health Innovative Technology (GHIT) Fund